Text-based Intervention to Minimize the Time Burden of Routine Cancer Care (TIME)

Abramson Cancer Center at Penn Medicine

Status: Completed

Conditions: Solid Tumor; Patient Empowerment; Cancer; Telemedicine

Treatments: Other: Text triage

Study type: Interventional

Funder types: Other

Identifiers

NCT05134636

UPCC 16921

Details and patient eligibility

About

The primary objective is to test whether a text-based e-triage can safely minimize the time associated with routine cancer care by identifying patients who can proceed directly to their immunotherapy infusion without a preceding in-person office assessment.

Enrollment: 40 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Over 18 years of age
• Initiating singe agent PDL-1/PD-1 targeted immune checkpoint blockade for any solid malignancy at Penn's Abramson Cancer Center
• Access to a mobile phone with texting capabilities
• ECOG performance status less than or equal to 2

Exclusion criteria

• Non-English speaking
• Unable to perform informed consent

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

Treatment Arm

Experimental group

Description:

For patients in the intervention arm, symptoms and laboratory results will be assessed using the text-based e-triage 96 hours prior to their intended infusion date. The e-triage will consist of a standardized questionnaire and algorithm to evaluate symptoms and laboratory values. Patients with acceptable labs and minimal or no symptoms can opt to proceed directly to their immunotherapy infusion without an in-person office assessment.

Treatment:

Other: Text triage

Usual Care

No Intervention group

Description:

Patients in the usual care arm will receive standard of care symptom monitoring including an in-person office assessment prior to their scheduled immunotherapy infusion.